TickerFacts.

Jaguar Health, Inc. (JAGX): Cost of Revenue

Annual figures by period end, from SEC filings.

$3.77M
Year ended 2025-12-31
$4.92M
Trailing 12 months to 2026-06-30
+23.2%
3-year compound annual growth
+2.8%
5-year compound annual growth
+40.8%
10-year compound annual growth
$3.82M2015-12-31: $123.5K2016-12-31: $52.0K2017-12-31: $880.4K2018-12-31: $2.77M2019-12-31: $3.82M2020-12-31: $3.28M2021-12-31: $2.33M2022-12-31: $2.02M2023-12-31: $2.04M2024-12-31: $1.96M2025-12-31: $3.77M$3.77M
2015-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$3.77M+93.0%2026-04-07, From 2025-01-01
2024-12-31$1.96M-4.0%2026-04-07, From 2024-01-01
2023-12-31$2.04M+0.9%2025-03-31, From 2023-01-01
2022-12-31$2.02M-13.5%2024-04-01, From 2022-01-01
2021-12-31$2.33M-28.9%2023-03-24, From 2021-01-01
2020-12-31$3.28M-14.0%2022-03-11, From 2020-01-01
2019-12-31$3.82M+38.0%2021-03-31, From 2019-01-01
2018-12-31$2.77M+214.1%2020-04-03, From 2018-01-01
2017-12-31$880.4Kn/m2019-04-10, From 2017-01-01
2016-12-31$52.0K-57.9%2018-04-09, From 2016-01-01
2015-12-31$123.5Kn/a2017-02-15, From 2015-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Jaguar Health, Inc. (JAGX)2025-12-31$3.77M+93.0%
Emmaus Life Sciences, Inc. (EMMA)2025-12-31$857.0K-28.6%
Tonix Pharmaceuticals Holding Corp. (TNXP)2025-12-31$6.64M-14.5%
CV Sciences, Inc. (CVSI)2025-12-31$7.04M-17.6%
Pyxis Oncology, Inc. (PYXS)2025-12-31$2.39M+402.7%
International Stem Cell Corp (ISCO)2025-12-31$4.03M+7.1%
uniQure N.V. (QURE)2025-12-31$1.69M+33.1%
Aclaris Therapeutics, Inc. (ACRS)2025-12-31$2.09M-25.1%
Whitehawk Therapeutics, Inc. (WHWK)2025-12-31$760.0K-74.9%

Compare JAGX, EMMA, TNXP, CVSI side by side · Screen every company in Pharmaceutical Preparations ↗